Israel - English - Ministry of Health

rafa laboratories ltd - cetalkonium chloride; choline salicylate - gel - cetalkonium chloride 0.01 %w/w; choline salicylate 8.7 %w/w - choline salicylate - choline salicylate - as an antiseptic and local pain reliever for mouth ulcers, teething pain, denture irritation, and cold sores.

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - choline salicylate; cetalkonium chloride - oromucosal gel - 8.714%w/w +0.010 percent weight/weight - salicylic acid and derivatives; choline salicylate

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - choline salicylate; cetalkonium chloride - oromucosal gel - 8.714 %w/w+ 0.010 percent weight/weight - salicylic acid and derivatives; choline salicylate

Israel - English - Ministry of Health

rafa laboratories ltd - cetalkonium chloride; choline salicylate - gel - cetalkonium chloride 0.01 %w/w; choline salicylate 8.7 %w/w - choline salicylate - choline salicylate - as an antiseptic and local pain reliever for mouth ulcers, teething pain, denture irritation, and cold sores.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma marketing sdn. bhd. - choline salicylate 80% solution; cetalkonium chloride -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma marketing sdn. bhd. - cetalkonium chloride; choline salicylate 80% solution -

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - amitriptyline hydrochloride 10 mg - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with a gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardial infa

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - oxybutynin chloride (unii: l9f3d9renq) (oxybutynin - unii:k9p6mc7092) - oxybutynin chloride 5 mg - oxybutynin chloride tablets are indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria). oxybutynin chloride is contraindicated in patients with urinary retention, gastric retention and other severe decreased gastrointestinal motility conditions, uncontrolled narrow-angle glaucoma and in patients who are at risk for these conditions. oxybutynin chloride is also contraindicated in patients who have demonstrated hypersensitivity to the drug substance or other components of the product.

United States - English - NLM (National Library of Medicine)

lifestar pharma llc - succinylcholine chloride (unii: i9l0ddd30i) (succinylcholine - unii:j2r869a8yf) - succinylcholine chloride injection is indicated in adults and pediatric patients: - as an adjunct to general anesthesia - to facilitate tracheal intubation - to provide skeletal muscle relaxation during surgery or mechanical ventilation. succinylcholine chloride injection is contraindicated: - in patients with skeletal muscle myopathies [see warnings and precautions (5.1)] - in patients with known hypersensitivity to succinylcholine. severe anaphylactic reactions to succinylcholine have been reported [see warnings and precautions (5.2)] - after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, which may result in severe hyperkalemia and cardiac arrest [see warnings and precautions (5.4)] - in patients with known or suspected genetic susceptibility to malignant hyperthermia [see warnings and precautions (5.5), clinical pharmacology (12.5)] risk summary available data from published literature from case reports and case ser

Australia - English - Department of Health (Therapeutic Goods Administration)

reckitt benckiser pty ltd - choline salicylate, quantity: 8.714 % w/w - gel - excipient ingredients: star anise oil; glycerol; purified water; saccharin sodium; hypromellose; cetalkonium chloride; menthol; ethanol - provides fast-acting, soothing relief from the pain and discomfort associated with infant teething disorders, mouth ulcers and sores, and new dentures.